Department of Neurology, School of Medicine, Stanford University, Stanford, CA, USA.
Department of Neurology, The David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Expert Rev Med Devices. 2023 Jun;20(6):433-447. doi: 10.1080/17434440.2023.2202815. Epub 2023 May 15.
Migraine is a prevalent, inherited and disabling brain disease with multiple symptoms and a variety of treatment options. Nerivio, utilizing remote electrical neuromodulation (REN) a wearable device, offers users good efficacy, tolerability and safety. It is user-friendly, affordable, non-addictive and cleared by the FDA and the European Conformity.
The device structure, mechanism of action, indications for use, application instructions, efficacy, adverse events, tolerability, safety, patient satisfaction, associated application and the research highlights are discussed herein.
The device works well for most people living with migraine, often without concomitant medication, is tolerable, safe and causes minimal and mild adverse effects. It expands our migraine treatment options and improves patient adherence to treatment. Nerivio is easy-to-use and can be worn at any time of the day; it provides a non-pharmacologic option for the optimization of migraine treatment without significant adverse events.
偏头痛是一种常见的、遗传性的、使人丧失能力的脑部疾病，具有多种症状和多种治疗选择。Nerivio 是一种利用远程电神经调节（REN）的可穿戴设备，为用户提供了良好的疗效、耐受性和安全性。它易于使用、价格实惠、无成瘾性，并且已获得 FDA 和欧盟合格认证。
本文讨论了该设备的结构、作用机制、适应证、使用说明、疗效、不良事件、耐受性、安全性、患者满意度、相关应用和研究亮点。
对于大多数偏头痛患者来说，该设备效果良好，通常无需伴随药物治疗，具有良好的耐受性、安全性且副作用极小且轻微。它扩大了我们偏头痛的治疗选择，提高了患者对治疗的依从性。Nerivio 使用方便，可在一天中的任何时间佩戴，为优化偏头痛治疗提供了一种非药物选择，且不会产生重大不良事件。
